Connect with us

India

Covaxin trial on children begins at AIIMS Patna: Report

Published

on

Covaxin trial on children begins at AIIMS Patna: Report

India has begun the clinical trial of Bharat Biotech’s Covaxin on children. In a tweet, Prasar Bharati said that the testing is being done at the All India Institute of Medical Sciences (AIIMS) Patna.

Last month, senior NITI Aayog member VK Paul had announced that the phase II/III clinical trials of Covaxin will be done on those aged between two and 18. The trial was to be conducted on 525 subjects, according to him.

Covaxin is a vaccine indigenously developed by the Hyderabad-based company, in association with the Indian Council of Medical Research. It was one of the first two deployed by the Centre in its nationwide Covid inoculation drive.

Most nations are yet to approve any vaccine for the use of children. Last month, the US and Canada authorised Pfizer-BioNTech’s vaccine for use in some age groups of children.

India

Amit Shah: India handled Covid-19 in best possible way despite limited resources

Published

on

By

Amit Shah: India handled Covid-19 in best possible way despite limited resources

On Tuesday, Union Home Minister Amit Shah said that India has handled the Covid-19 pandemic in the best possible manner among all countries in the world despite limited resources.

Addressing the 17th formation day of the National Disaster Management Authority (NDMA) here, Shah also said that the Centre is planning to roll out the ‘Aapda Mitra’ (Friends in Disaster) project in 350 districts across the country by imparting training to citizens as first responders to any disaster.

He added that despite limited resources and with such a large population of 130 crore, India has fought the Covid-19 pandemic in the best possible manner among all countries.

 

Continue Reading

India

ICMR bats for reopening of primary schools

Published

on

By

ICMR bats for reopening of primary schools

A paper published in the Indian Journal of Medical Research by the Indian Council of Medical Research (ICMR) has recommended that schools in the country avoid “routine temperature checks” owing to “limited evidence” of their utility.

“It must also be acknowledged that testing strategies for SARS-CoV-2 infection in schools should act as an adjunct and not substitute to other organizational and behavioural interventions,” says the study authored by ICMR Director-General Dr Balram Bhargava, Samiran Panda and Tanu Anand.

“Routine temperature or symptom checking in schools should be avoided due to limited evidence of their utility. It is also recommended that schools should have access to onsite testing facilities as per existing country-specific guidelines,” the paper published in the Indian Journal of Medical Research read.

Continue Reading

India

CoWin certificates to mention date of birth of fully vaccinated travelling abroad

Published

on

By

CoWin certificates to mention date of birth of fully vaccinated travelling abroad

According to the official sources, people, who have fully vaccinated and want to travel abroad, will have a CoWin certificate with their full date of birth.

This happened amidst the ongoing discussions between India and the UK over Covid vaccination certificates.

Currently, CoWin certificates mention the beneficiary’s age based on the year of birth besides other details.

The new feature is being introduced in compliance with the WHO norms and is likely to be available from next week.

“It has been decided that a new feature will be added to the CoWin under which those who are fully vaccinated and want to travel abroad will have full date of birth on their vaccination certificates,” an official source said.

Continue Reading

Trending